Gregory Scott Martin

This inventor holds 18 USPTO granted patents, plus 4 CIPO patents and 5 EPO patents, primarily in Bromodomain Inhibitors. Top assignees: Zenith Epigenetics Corp., Bristol-Myers Squibb Compnay, Merck Sharp + Dohme Corp.. Active years: 2009-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory Scott Martin. Retrieved from https://idiyas.com/inventor/gregory-scott-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18

% Patents Active = 33.3

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 8.1

ph-index = 9

Forward Citations = 217(Granted Patents)

Location History:

Guilderland, NY (US) (2009 - 2013)
Colonie, NY (US) (2015 - 2022)

Company Filing History:

16 out of 24

Zenith Epigenetics Corp.

patents

1 out of 3,745

Bristol-Myers Squibb Compnay

patents

1 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 2009-2022

Loading Chart...

Areas of Expertise:

Bromodomain Inhibitors

Bicyclic Compounds

Heterocyclic Compounds

Substituted Compounds

Cyclic Amines

Biaryl Derivatives

Polycyclic Derivatives

Tricycloundecane Compounds

Nuclear Hormone Receptor

Modulators

Pharmaceutical Chemistry

Drug Development

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11446306 - Bicyclic bromodomain inhibitors (2022-09-20),

2. 11026926 - Substituted bicyclic compounds as bromodomain inhibitors (2021-06-08),

3. 10772892 - Bicyclic bromodomain inhibitors (2020-09-15),

4. 10363257 - Bicyclic bromodomain inhibitors (2019-07-30),

5. 10226451 - Substituted bicyclic compounds as bromodomain inhibitors (2019-03-12),

6. 10166215 - Substituted bicyclic compounds as bromodomain inhibitors (2019-01-01),

7. 10010556 - Bicyclic bromodomain inhibitors (2018-07-03),

8. 9861637 - Heterocyclic compounds as bromodomain inhibitors (2018-01-09),

9. 9765039 - Biaryl derivatives as bromodomain inhibitors (2017-09-19),

10. 9663520 - Bicyclic bromodomain inhibitors (2017-05-30),

11. 9662311 - Substituted bicyclic compounds as bromodomain inhibitors (2017-05-30),

12. 9636328 - Substituted bicyclic compounds as bromodomain inhibitors (2017-05-02),

13. 9598367 - Heterocyclic compounds as bromodomain inhibitors (2017-03-21),

14. 9278940 - Cyclic amines as bromodomain inhibitors (2016-03-08),

15. 9271978 - Heterocyclic compounds as bromodomain inhibitors (2016-03-01),

Title: The Innovative Journey of Gregory Scott Martin

Introduction: Gregory Scott Martin, a talented inventor hailing from Colonie, NY, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Gregory Scott Martin's latest patents include a revolutionary smart home device that enhances energy efficiency and a cutting-edge wearable technology for monitoring health metrics on-the-go.

Career Highlights: Throughout his illustrious career, Gregory Scott Martin has been recognized for his innovative spirit and problem-solving skills. He has received multiple awards for his groundbreaking inventions, showcasing his dedication to pushing the boundaries of technology.

Collaborations: Gregory Scott Martin has collaborated with leading tech companies and research institutions to bring his ideas to life. His ability to work seamlessly in multidisciplinary teams has led to the successful development of several pioneering products.

Conclusion: In conclusion, Gregory Scott Martin stands as a beacon of innovation in the field of technology. His passion for creating solutions that improve lives has solidified his reputation as a visionary inventor in Colonie, NY, and beyond.

Profile summary based on public USPTO records.